|
|
|
|
|
|
|
|
|
11.09.26 - 05:18
|
Yuen Kee Food enters final stage of Hong Kong IPO after HKEX approval, sources say (SCMP)
|
|
|
Yuen Kee Food Group, the owner of well-known restaurant brand Yuen Kee Dumpling, has cleared its listing hearing with the Hong Kong Exchanges and Clearing (HKEX), aiming to raise between HK$300 million (US$38.3 million) and HK$400 million, according to people familiar with the matter.
The conclusion of the hearing marked its initial public offering (IPO) plan entering its final stage, and the company planned to kick off the offering in October, the sources said, who asked not to be named because......
|
|
|
|
|
|
|
11.09.26 - 01:00
|
Hong Kong home prices headed for 15% gain this year, Midland forecast says (SCMP)
|
|
|
Hong Kong's home prices will end the year 15 per cent higher than a year earlier, but still 16 per cent below their high-water mark in 2021, according to local property agency Midland Realty.
Underpinning the positive forecast, the city's banks were not likely to follow an increase in US interest rates by the Federal Reserve if one occurred this year, executives from the agency said at a press conference on Thursday.
Dave Ma Tai-yeung, CEO of Midland (Residential), said that as the market......
|
|
|
10.09.26 - 14:30
|
SHKP posts 4.6% profit rise amid Hong Kong′s property recovery (SCMP)
|
|
|
Sun Hung Kai Properties (SHKP), Hong Kong's biggest developer by market capitalisation, reported its underlying profit for the year ending June rose 4.6 per cent to HK$22.85 billion (US$2.91 billion), excluding investment property revaluations.
Meanwhile, its reported profit increased to HK$21.43 billion, backed by a HK$1.38 billion net revaluation gain versus a HK$742 million loss last year, according to its filing with the Hong Kong stock exchange on Thursday.
“For the year under review, Hong......
|
|
|
|
|
|
|
10.09.26 - 12:12
|
Hong Kong watchdog investigates Cloudbreak Pharma for ′rigged′ IPO, suspends its shares (SCMP)
|
|
|
Hong Kong's Securities and Futures Commission (SFC) has directed the stock exchange to suspend trading of US-based biotech firm Cloudbreak Pharma pending an investigation into its US$78 million initial public offering (IPO) last year.
“The SFC has serious concerns that Cloudbreak's initial public offering may have been rigged to create an artificial impression of demand for Cloudbreak's shares,” the SFC said in a statement on Thursday.
The regulator considered the suspension “necessary or......
|
|
|
10.09.26 - 11:06
|
Hong Kong IPO′s 177% Pop Highlights Quirk in Allocation Rules (Bloomberg)
|
|
|
A 177% debut surge on Wednesday by Excelland Robotics Wuxi Co. is putting a spotlight on Hong Kong's rules for allocating shares in initial public offerings after the listing left almost 94% of the shares in institutional hands despite strong demand from retail investors....
|
|
|
|
|
10.09.26 - 09:54
|
Kimi maker Moonshot AI to explore dual Hong Kong and Shanghai IPOs to boost capital: sources (SCMP)
|
|
|
Chinese artificial intelligence start-up Moonshot AI, developer of the popular Kimi K3 model, may explore options for dual listings in Hong Kong and Shanghai in pursuit of greater capital and exposure, according to two people familiar with the matter.
Since a meeting with its financial backers in July, when the Beijing-based company announced plans for an initial public offering in Hong Kong, it has hinted at options to also list on a mainland bourse afterwards, one source said.
On the mainland,......
|
|
|
10.09.26 - 09:06
|
Aktien Asien: Ölpreise belasten Stimmung - Hongkong schwach (DPA-AFX)
|
|
|
SEOUL/TOKIO/HONGKONG/SHANGHAI (dpa-AFX) - Der Handel an den asiatischen Aktienmärkten war am Donnerstag von Vorsicht geprägt. Gedrückt wurde die Stimmung von der Sorge um eine Ausweitung des Iran-Kriegs. Zudem schürten die hohen Ölpreise weiter Inflationsängste ......
|
|
|
10.09.26 - 09:00
|
Mainland Chinese shoppers lose trusted Hong Kong veggie tag as customs revamp hits shelves (SCMP)
|
|
|
Mainland Chinese supermarkets, including US warehouse retailer Sam's Club, have dropped the Hong Kong-bound vegetable label under new customs rules.
The change has triggered widespread concern among consumers, as the label had long served as a selling point for high quality amid frequent mainland food-safety incidents.
The removal stems from new rules by the General Administration of Customs. From September 1, registration will no longer be required for growing farms, and only food-processing......
|
|
|
|
|
10.09.26 - 07:00
|
Can Hong Kong stocks contend with wild swings without help from state hands? (SCMP)
|
|
|
As concerted state buying puts a floor under mainland China's onshore stock market amid Beijing's stabilisation measures, investors in Hong Kong worry about coping with high volatility at a delicate time, with multiple market-roiling factors.
These include geopolitical tensions, sluggish earnings growth, a stumbling artificial intelligence trade, possible US tightening and a looming supply glut from expiring share lock-ups.
Investor worries also grew after renewed military strikes in the Middle......
|
|
|
10.09.26 - 01:00
|
Susquehanna latest to pick up larger office space in Hong Kong′s Central, sources say (SCMP)
|
|
|
US investment firm Susquehanna International Group has agreed to lease more than 4,808 square metres (51,762 square feet) of office space at the Cheung Kong Center II, a prime office skyscraper developed by CK Asset Holdings in Hong Kong's main business zone of Central, according to market sources.
Neither Susquehanna nor CK Asset immediately replied to the South China Morning Post's requests for comments.
The new space would span three floors of the property, according to the......
|
|
|
09.09.26 - 11:30
|
Hong Kong targets biomedicine powerhouse status in debut five-year plan (SCMP)
|
|
|
Biomedicine is set to feature in Hong Kong's first five-year plan, due to be unveiled next week, as the city's top officials signal closer medical cooperation across the Greater Bay Area.
Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its role in the region's biotech development on Wednesday, at the fifth Hong Kong International Biotechnology Conference and Exhibition (BIOHK).
Speaking at the event, Hong Kong Secretary for Health Lo......
|
|
Top- News zu Hong Kong (China) 24804.748 +0.09% (Hang Seng Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
